Aprameya EngineeringNSE:APRAMEYA -0.41%42 EBIT per Share is ₹5.74 as of Mar. 2026. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 42/100. The stock has 6 warning signs investors should review. Among 687 Medical Devices & Instruments companies, Aprameya Engineering ranks worse than 57.64% on this metric.
Aprameya Engineering's EBIT per Share for the
six
months ended in Mar. 2026 was ₹5.74.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.74.
During the past 12 months, the average EBIT per Share Growth Rate of Aprameya Engineering was -60.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 3.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 22.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Aprameya Engineering's EBIT per Share or its related term are showing as below:
NSE:APRAMEYA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 2.3 Med: 20.8 Max: 81.7
Current: 3.8
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Aprameya Engineering was 81.70% per year. The lowest was 2.30% per year. And the median was 20.80% per year.
NSE:APRAMEYA's 3-Year EBIT Growth Rate is ranked worse than 57.64% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs NSE:APRAMEYA: 3.80
Aprameya Engineering (NSE:APRAMEYA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Aprameya Engineering EBIT per Share Related Terms
Aprameya Engineering EBIT per Share Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.74
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aprameya Engineering (NSE:APRAMEYA) has a EBIT per Share of ₹5.74 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Aprameya Engineering and its competitors. According to the industry distribution chart, Aprameya Engineering ranks #396 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 57.6%.
Is Aprameya Engineering's EBIT per Share too high?
Aprameya Engineering's current EBIT per Share is ₹5.74. Based on the distribution chart, Aprameya Engineering ranks #396 out of 687 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aprameya Engineering has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #396 out of 687 companies for EBIT per Share. This places Aprameya Engineering in the lower half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current EBIT per Share is ₹5.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current EBIT per Share of ₹5.74. The current EBIT per Share is ₹5.74. Aprameya Engineering's overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current EBIT per Share is ₹5.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
42GF Score
Get the complete analysis for NSE:APRAMEYA
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 